Company: SUPN
Filing Date: 2025-04-23
Form Type: 8-K
Source: 0001356576-25-000020
Chunk: 0

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-04-23
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02 Results of Operations and Financial Condition.

On April 23, 2025, Supernus Pharmaceuticals, Inc. issued a press release announcing that it expects to report its business results for the first quarter of 2025 after the market closes on Tuesday, May 6, 2025. The Company will host a conference call and webcast on Tuesday, May 6, 2025 at 4:30 p. m. E. T. to discuss its first quarter 2025 financial and business results. A copy of this press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.